Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies

Unifies World-Class Validated Circular RNA and Industry-leading Delivery Technologies to Advance New Category of panCAR in vivo CAR RNA Medicines for Oncology and Autoimmune Diseases Amit Munshi to L

PR NewswireMay 23 08:00 ET

Only Three Days Left To Cash In On Ornapaper Berhad's (KLSE:ORNA) Dividend

Yahoo FinanceApr 27 20:09 ET

Ornapaper Proposes to Diversify Into Property Business

Ornapaper Bhd said it plans to diversify into the property development and property investment business, as it expects this to contribute 25% or more to its future net profit.

The Edge MarketsApr 22 10:15 ET

Ornapaper Berhad (KLSE:ORNA) Is Increasing Its Dividend To MYR0.02

Yahoo FinanceApr 20 20:26 ET

Ortivus CFO to Step Down in July

Sweden's Ortivus (ORTI-B.ST, ORTI-A.ST) said Monday that Chief Financial Officer Viveka Hiort af Ornäs plans to step down on July 12. The e-health and medical technology company started the process o

MT NewswiresApr 15 06:44 ET

MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner

BOSTON, April 11, 2024 /PRNewswire/ -- MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver transformative therapies to patients, today ann

PR NewswireApr 11 08:00 ET